ISRCTN11497545已完成不适用
tility of 13C-methacetin breath test in predicting long-term survival of patients with decompensated cirrhosis
Health Research Council of Mexican Institute of Social Security0 个研究点目标入组 123 人开始时间: 2017年3月2日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 123
研究概览
简要总结
2017 results in https://www.ncbi.nlm.nih.gov/pubmed/28649974
研究设计
- 研究类型
- Observational
入排标准
- 性别
- All
入选标准
- •1. Age above 18 years
- •2. Diagnosis of decompensated cirrhosis based on history of present illness, clinical and biochemical findings combined with ultrasonographic results, plus liver biopsy when possible
排除标准
- •Hepatocarcinoma
研究者
相似试验
已完成
不适用
Prediction Value of the BreathID 13C-Methacetin Breath Test for Hepatic DecompensationChronic Liver DiseaseNCT02084160Meridian Bioscience, Inc.579
Unknown
2 期
¹³C-Methacetin Breath Test (MBT) Methodology StudyHealthy SubjectsChronic Liver DiseaseCirrhosisNCT01205074Hadassah Medical Organization
终止
2 期
BreathID Multi-center HCV Liver Breath Test StudyHepatitis CNCT00350714Meridian Bioscience, Inc.75
已完成
不适用
Role of 13C Methacetin Breath Test in Predicting Prognosis Among Patients With Acute or Acute on Chronic Liver Failure (ACLF).Acute on Chronic Liver FailureAcute Liver FailureNCT01946360Institute of Liver and Biliary Sciences, India24
已完成
不适用
Companion Protocol for Methacetin Breath Test (MBT) in Conatus Protocol IDN-6556-14NASH - Nonalcoholic SteatohepatitisCirrhosisPortal HypertensionNCT03439189Meridian Bioscience, Inc.343